Ankylosing spondylitis trials in Canada
5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Calgary, Montreal, Saskatoon
- Age
- 2 years to 18 years
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - Phase 2Taking peopleA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
- Where
- Québec, Toronto, Trois-Rivières
- Age
- 18 years to 80 years
- People
- 315 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00 - Phase 1Taking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Calgary, Vancouver
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - No phaseTaking peopleExactech Shoulder Post Market Clinical Follow-up Study
- Where
- London
- Age
- 21 years and over
- People
- 20,000 worldwide
- Run by
- Exactech
See details and how to joinNCT05603728 - Phase 4Taking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Ottawa, Québec
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00